Pendapatan operasional sadurunge ngurangi amortisasi: Silo Pharma Inc. (SILO)

Tandha merek Silo Pharma, Inc. (SILO)

The development of Silo Pharma, Inc. (SILO) is based on clinical trials of psychedelics for the treatment of depression and fibromyalgia while maintaining a stable balance. The company's EBITDA demonstrates current cash flow resilience, with the metric standing at 0.00. The firm is implementing microdosing to combat pain without inducing hallucinations, and is also researching the effects of psilocybin on PTSD and Alzheimer's disease.

Bathi operasional EBITDA Silo Pharma (SILO): kanggo periode 23.11.2025 - 12.11.2026

Ringkesan rincian data analitis Silo Pharma, Inc. (SILO)

- rega saham lan konsensus proyeksi valuasi:
Bagan kutipan Silo Pharma Inc.|SILO - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Silo Pharma|SILO - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- data ekuitas miturut neraca:
Nilai Aset Bersih saben Saham Silo Pharma|SILO - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih silopharma.com|SILO - Total Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Rasio Kabeh Utang marang Dana Pribadi Silo Pharma, Inc.|SILO - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal silopharma.com|SILO - Utang perusahaan|Utang-utang marang aset resik Silo Pharma|SILO - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Silo Pharma|Likuiditas cepet silopharma.com
- rincian bathi lan kelipatan pasar:
SILO - Bathi resik perusahaan|Bathi resik sing dikarepake Silo Pharma, Inc.|SILO - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Silo Pharma Inc.|SILO - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Silo Pharma|SILO - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Silo Pharma|SILO - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan silopharma.com|SILO - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Silo Pharma, Inc.
Analisis kabeh metrik perusahaan:SILO Silo Pharma Inc.
Produk merek Silo Pharma, Inc.

For biopharmaceutical innovator Silo Pharma, Inc. (SILO), which is developing depression therapies, this indicator captures the actual volume of cash generated, excluding non-cash expenses and the impact of credit policy. The metric allows for an assessment of operational cost management efficiency and cash flow predictability, which is critical for evaluating the sustainability of R&D projects by analyzing the absolute EBITDA trend for hidden costs.

Karo sapa Silo Pharma, Inc. saingan

ALKS (Alkermes Corp) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|AVDL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi atai.life ATAI|GHRS (GH Research) - Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge bunga, pajak, lan amortisasi Mind Medicine (MindMed) Inc. (MNMD)|CMPS (Compass Pathways) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi LB Corp (LBRX)|Bathi operasional EBITDA DRUG|VNDA (vandapharma.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cybin CYBN|Alto Neuroscience Inc (ANRO) - Bathi sadurunge bunga, pajak, lan amortisasi|NRXP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Cingulate Inc. CING|CPHI: Bathi operasional EBITDA|CMND - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Psyence Biomedical|Bathi sadurunge mbayar bunga, pajak, lan amortisasi SPRC|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Seelos Therapeutics, Inc (SEEL)|VRPX - Bathi sadurunge bunga, pajak, lan amortisasi|Karuna Therapeutics - Bathi operasional sadurunge ngurangi amortisasi